Atlas Trials

A Non-randomised, Non-inferiority Comparative Study of Oral Actiskenan (Morphine Sulfate) Versus Intranasal Sufentanil in the Early Management of Severe Acute Pain in Emergency Departments.

Clinical trial NCT07344350 · WITHDRAWN

Trial details

NCT number
NCT07344350
Sponsor
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Status
WITHDRAWN
Study type
OBSERVATIONAL
Severe Acute Pain
Start date
2026-01-31
Primary completion
2026-05-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.